Veritas In Silico (TSE:130A) Total Liabilities: 円122.03 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:130A Veritas In Silico Inc TSE:130A
28 GF Score
Price 円433.00
GF Value 円266.78
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Veritas In Silico Total Liabilities?

Veritas In Silico TSE:130A -2.26% 28 Total Liabilities is 円122.03 Mil as of Jun. 2026. GuruFocus rates TSE:130A with a GF Score™ of 28/100 and a GF Value™ of 円266.78 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Veritas In Silico's Total Liabilities for the quarter that ended in Jun. 2026 was 円122.03 Mil.

Veritas In Silico's quarterly Total Liabilities increased from Dec. 2025 (円101.04 Mil) to Mar. 2026 (円257.88 Mil) but then declined from Mar. 2026 (円257.88 Mil) to Jun. 2026 (円122.03 Mil).

Veritas In Silico's annual Total Liabilities declined from Dec. 2023 (円79.89 Mil) to Dec. 2024 (円39.41 Mil) but then increased from Dec. 2024 (円39.41 Mil) to Dec. 2025 (円101.04 Mil).

Veritas In Silico Total Liabilities Historical Data

* Premium members only.

The historical data trend for Veritas In Silico's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veritas In Silico Total Liabilities Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
70.82 55.99 79.89 39.41 101.04

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.84 60.73 101.04 257.88 122.03
TSE:130A
28GF Score
Veritas In Silico Inc TSE:130A
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veritas In Silico Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Veritas In Silico's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=101.035+(0+0.0010000000000048
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=101.04

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1884.912-1783.876
=101.04

Veritas In Silico's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=91+(0+31.027
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=122.03

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=1519.286-1397.259
=122.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of 円122.03 Mil mean?
Veritas In Silico (TSE:130A) has a Total Liabilities of 円122.03 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Veritas In Silico and its competitors.
Is Veritas In Silico's Total Liabilities too high?
Veritas In Silico's current Total Liabilities is 円122.03 Mil. Overall, Veritas In Silico has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Veritas In Silico's Total Liabilities compare to VRTX and REGN?
Veritas In Silico's Total Liabilities of 円122.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Veritas In Silico and its competitors. Veritas In Silico's current Total Liabilities is 円122.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veritas In Silico stock overvalued right now?
Based on GuruFocus' analysis, Veritas In Silico (TSE:130A) is currently considered Significantly Overvalued. The stock's GF Value™ is 円266.78, compared to a current price of 円433.00 — trading 62.3% above its estimated fair value. The current Total Liabilities is 円122.03 Mil. Veritas In Silico's overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Veritas In Silico (TSE:130A), the current Total Liabilities is 円122.03 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Veritas In Silico (TSE:130A) Overvalued in 2026?

Based on GuruFocus' analysis, Veritas In Silico stock appears to be overvalued. The current stock price of 円433.00 is trading 62.3% above its estimated GF Value™ of 円266.78. GuruFocus considers Veritas In Silico to be Significantly Overvalued.

Key valuation signals for TSE:130A:

  • Total Liabilities: 円122.03 Mil
  • GF Value™: 円266.78 vs. price of 円433.00 (62.3% above fair value)
  • GF Score™: 28/100 with 4 warning signs

No single metric tells the full story. See the TSE:130A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Veritas In Silico Business Description

Address 1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.
28GF Score

Get the complete analysis for TSE:130A

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円433.00
Price
円266.78
GF Value